HomeWebcastDaimler AG v. Bauman and its Impact in Hatch-Waxman Lawsuits’ Personal Jurisdiction Challenges
Impact in Hatch-Waxman Lawsuits' CLE/CPE CLE

Daimler AG v. Bauman and its Impact in Hatch-Waxman Lawsuits’ Personal Jurisdiction Challenges

Live Webcast Date: Friday, July 10, 2015 from 3:00 pm to 5:00 pm (ET)
Healthcare CLE & CPERecording

Impact in Hatch-Waxman Lawsuits' CLE/CPE

The Supreme Court's recent decision on the Daimler AG v. Bauman case has triggered significant changes in the Hatch - Waxman practice. The pharmaceutical industry  views the verdict as a basis to contest jurisdiction in Abbreviated New Drug Application (ANDA) cases.

In this CLE Webinar, a panel of distinguished professionals and thought leaders will help you better understand the important aspects of this significant topic. They will provide an in-depth discussion of the Daimler AG v. Bauman decision and its potential impact on Hatch-Waxman Lawsuits. Speakers will also share important insights on dealing with challenges, minimizing risks, and avoiding unnecessary delays in patent litigation.

Some of the major topics that will be covered in this course are:

  • Daimler AG v. Bauman Case – An Overview
  • General Jurisdiction Vs. Specific Jurisdiction
  • Personal Jurisdiction in Hatch-Waxman Lawsuits
  • Limitations, Challenges and Implications
  • Compliance and Risk Mitigation
  • Recent Personal Jurisdiction Cases
  • Best Practices to Avoid Unnecessary Delays in Patent Litigation
  • Possible Fines and Penalties

Agenda

SEGMENT 1:
Brian McMahon, Member
Christensen O'Connor Johnson Kindness PLLC
  • Brief overview of previous standard
  • Overview of Daimler
  • Very first case

SEGMENT 2:
Robert L. Florence, Shareholder
Workman | Nydegger
  • The decision – historical perspective

Who Should Attend

  • FDA Attorneys
  • Biotech/Pharmaceutical Industry Lawyers
  • Medical Directors
  • Life Sciences and Health Care Practice Consultants
  • In-House Counsel from Drug Manufacturing Companies
  • IP Attorneys & Consultants
  • Patent Licensing Attorneys
  • Patent Litigators
  • Patent Attorneys

Impact in Hatch-Waxman Lawsuits' CLE/CPE

SEGMENT 1:
Brian McMahon, Member
Christensen O'Connor Johnson Kindness PLLC
  • Brief overview of previous standard
  • Overview of Daimler
  • Very first case

SEGMENT 2:
Robert L. Florence, Shareholder
Workman | Nydegger
  • The decision – historical perspective

Impact in Hatch-Waxman Lawsuits' CLE/CPE

Impact in Hatch-Waxman Lawsuits' CLE/CPE

Brian McMahonMemberChristensen O'Connor Johnson Kindness PLLC

Brian McMahon focuses his practice specifically on intellectual property litigation matters and is the leader of the firm's Hatch-Waxman "ANDA" litigation practice. He also has extensive experience representing clients ranging from Fortune 100 companies to individual inventors, involving technologies relating to chemical, mechanical, and electrical arts alike. He has appeared before the United States Court of Appeals for the Federal Circuit, several federal district courts, and the United States International Trade Commission.  Brian clerked for then-Chief Judge H. Robert Mayer of the U.S. Court of Appeals for the Federal Circuit following his graduation from Georgetown University Law Center, and he earned his B.S. degree from the United States Military Academy at West Point.

Impact in Hatch-Waxman Lawsuits' CLE/CPE

Robert L. FlorenceShareholderWorkman | Nydegger

Mr. Florence is a registered patent attorney who focuses his practice on patents and trademarks, and related business litigation with specific emphasis on complex pharmaceutical patent litigation brought under the Hatch-Waxman Act.  He is known nationally for his Abbreviated New Drug Application (“ANDA”) expertise and has extensive experience counseling generic pharmaceutical companies regarding ANDA filings, pre-litigation strategies, defending such companies in patent litigation, and preparing and submitting citizen petitions. Mr. Florence handles litigation from inception through trial and has litigated cases before both state and federal courts and the American Arbitration Association. He has negotiated and prepared numerous commercial agreements including licensing, assignment of rights, development, indemnification, non-disclosure, non-compete, employment and settlement agreements.


Click Here to Read Additional Material

Impact in Hatch-Waxman Lawsuits' CLE/CPE

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   On-demand Webcast

Prerequisite:
   NONE

Course Code:
   155384

NASBA Field of Study:
   Specialized Knowledge and Applications

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    2.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Christensen O'Connor Johnson KindnessPLLC (COJK) is a Seattle-based intellectual property law firm providing legal services in all areas of intellectual property, including patents, trademarks, litigation, licensing, trade secrets, and copyrights. COJK was founded in 1929, and has established itself as one of the Northwest's premier IP law firms.

The attorneys at COJK are committed to seeking and delivering strategic advantages for a wide range of clients, including industry leaders in biotechnology, consumer goods, entertainment, food services and processing, medical devices, pharmaceuticals, pulp and paper, semiconductors, software, and telecommunications. COJK's diverse, collaborative, and dedicated team of attorneys and paralegals provides comprehensive representation to enhance the long-term market value of clients' intellectual property assets.

Website: https://www.cojk.com/

Workman Nydegger has been consistently recognized as one of the top intellectual property firms in the nation. Workman Nydegger’s attorneys, located in offices in Salt Lake City, Utah and Atlanta, Georgia, represent a wide array of clients in all areas of intellectual property law including patent, trademark, copyright, unfair competition, and related litigation and licensing matters in a diverse range of technologies including computer systems, software, e-commerce and information technology; electronics and electrical engineering; pharmaceutical, nutraceutical, chemical, biotechnology, medical and life science technologies; physics and optics; mechanics and mechanical engineering, and alternative energy. For additional information, please visit www.wnlaw.com.

Website: https://www.wnlaw.com/

Brian McMahon focuses his practice specifically on intellectual property litigation matters and is the leader of the firm's Hatch-Waxman "ANDA" litigation practice. He also has extensive experience representing clients ranging from Fortune 100 companies to individual inventors, involving technologies relating to chemical, mechanical, and electrical arts alike. He has appeared before the United States Court of Appeals for the Federal Circuit, several federal district courts, and the United States International Trade Commission.  Brian clerked for then-Chief Judge H. Robert Mayer of the U.S. Court of Appeals for the Federal Circuit following his graduation from Georgetown University Law Center, and he earned his B.S. degree from the United States Military Academy at West Point.

Mr. Florence is a registered patent attorney who focuses his practice on patents and trademarks, and related business litigation with specific emphasis on complex pharmaceutical patent litigation brought under the Hatch-Waxman Act.  He is known nationally for his Abbreviated New Drug Application (“ANDA”) expertise and has extensive experience counseling generic pharmaceutical companies regarding ANDA filings, pre-litigation strategies, defending such companies in patent litigation, and preparing and submitting citizen petitions. Mr. Florence handles litigation from inception through trial and has litigated cases before both state and federal courts and the American Arbitration Association. He has negotiated and prepared numerous commercial agreements including licensing, assignment of rights, development, indemnification, non-disclosure, non-compete, employment and settlement agreements.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199